{"groups":[{"description":"Single administration dose cohorts, given in a single intravenous infusion of CAR-T cells. Rimiducid may be administered as indicated.","id":"FG000","title":"Phase 1: P-BCMA-101 CAR-T Cells"},{"description":"Single dose given across two intravenous infusions of CAR-T cells. Rimiducid may be administered as indicated.","id":"FG001","title":"Phase 1 P-BCMA-101 CAR-T Cells (Cohort A)"},{"description":"Single dose given across three intravenous infusions of CAR-T cells. Rimiducid may be administered as indicated.","id":"FG002","title":"Phase 1 P-BCMA-101 CAR-T Cells (Cohort B)"},{"description":"Single intravenous infusion of CAR-T cells, with combination therapy, beginning one week before CAR-T infusion.","id":"FG003","title":"Phase 1 P-BCMA-101 CAR-T Cells With Comb.Therapy (Cohort R)"},{"description":"Single intravenous infusion of CAR-T cells, with combination therapy, beginning one week before apheresis. Rimiducid may be administered as indicated.","id":"FG004","title":"Phase 1 P-BCMA-101 CAR-T Cells With Comb.Therapy (Cohort RP)"},{"description":"Single intravenous infusion of CAR-T cells, with combination therapy, beginning one week before CAR-T infusion. Rimiducid may be administered as indicated.","id":"FG005","title":"Phase 1 P-BCMA-101 CAR-T Cells With Comb.Therapy (Cohort RIT)"},{"description":"CAR-T cells administered via intravenous infusion as a total dose","id":"FG006","title":"Phase 2: P-BCMA-101 CAR-T Cells"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"2"},{"groupId":"FG006","numSubjects":"0"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"52"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"6"},{"groupId":"FG004","numSubjects":"5"},{"groupId":"FG005","numSubjects":"10"},{"groupId":"FG006","numSubjects":"3"}],"type":"Significant progression of malignancy requiring alternative, medical, radiation or surgical interven"},{"reasons":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"2"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"4"},{"groupId":"FG006","numSubjects":"0"}],"type":"Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"}],"type":"other reason not listed above"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"69"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"8"},{"groupId":"FG004","numSubjects":"5"},{"groupId":"FG005","numSubjects":"16"},{"groupId":"FG006","numSubjects":"3"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"}],"comment":"Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"66"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"8"},{"groupId":"FG004","numSubjects":"5"},{"groupId":"FG005","numSubjects":"16"},{"groupId":"FG006","numSubjects":"3"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}